Delivery Order SPE2DR25D1100-SPE2DR26FCS1E
Award Date 12/1/25
Potential Completion Date 12/22/25
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,341.84 to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vials, with an ultimate completion date of December 23, 2025. This is a firm fixed-price contract with no set-aside designation, representing a competitively awarded procurement. The contract work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,386.04 to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vials. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 15, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,079.06 to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vials, with an ultimate completion date of September 29, 2025. This is a firm fixed-price, non-set-aside contract issued on September 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The...
- The Defense Logistics Agency awarded a $1,790.80 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of HYPERRAB 300 Unit/ML Vial 5ML, with completion targeted for October 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the contractor's pharmaceutical supply services to the federal government. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $17,908 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of HYPERRAB 300 Unit/ML vial in 5ML quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 14, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $14,053.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vials (5ML) on May 30, 2025, with an ultimate completion date of June 23, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded without set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/mL vials, with a ceiling value of $4,158.12. This is a firm fixed price delivery order with no set-aside designation, awarded on August 4, 2025, with an ultimate completion date of August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under a larger contract vehicle and...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 21, 2025, for the supply of HYPERRAB 300 Unit/ML Vial pharmaceutical product. This firm fixed-price delivery order carries a ceiling value of $3,465.10 with an ultimate completion date of October 10, 2025, and was awarded without set-aside designations through competitive procedures. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of HYPERRAB 300 Unit/mL Vial 5mL, with a ceiling value of $1,733.74 and an ultimate completion date of November 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania. The order represents a child contract under the company's broader...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,744.80 on July 30, 2025, for the supply of HYPERRAB 300 Unit/mL vials (5mL) to support federal medical procurement needs. The award is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 20, 2025, and is funded through the Defense Logistics Agency's Medical Supply Chain division. This contract represents...